Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Reynolds

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Clinical Chemistry|March 26, 2003
Accuracy of cardiovascular risk estimationTimothy M Reynolds, Patrick Twomey, Anthony S Wierzbicki
Journal of Cardiovascular Risk|October 24, 2002
Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetesTimothy M Reynolds, Patrick Twomey, Anthony S Wierzbicki
Current Opinion in Cardiology|March 22, 2018
An update on trials of novel lipid-lowering drugsAnthony S Wierzbicki, Timothy M Reynolds, Adie Viljoen
Lancet (London, England)|April 13, 2005
Cardiovascular risk assessmentAnthony S Wierzbicki, Patrick J Twomey, Timothy M Reynolds
Current Medical Research and Opinion|December 23, 2003
Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for haemoglobin A1cPatrick J Twomey, Anthony S Wierzbicki, Timothy M Reynolds
Lancet (London, England)|April 4, 2003
More on PROSPERAnthony S Wierzbicki, Dimitri P Mikhailidis, Timothy M Reynolds
The American Journal of Cardiology|January 17, 2002
Usefulness of Orlistat in the treatment of severe hypertriglyceridemiaAnthony S Wierzbicki, Timothy M Reynolds, Martin A Crook
European Heart Journal|June 3, 2004
Screening for cardiovascular diseaseAnthony S Wierzbicki, Patrick J Twomey, Timothy M Reynolds
JAMA|April 22, 2004
Use of coronary calcification scores to predict coronary heart diseaseAnthony S Wierzbicki, Patrick J Twomey, Timothy M Reynolds
Current Medical Research and Opinion|June 18, 2004
Concordance evaluation of coronary risk scores: implications for cardiovascular risk screeningTimothy M Reynolds, Patrick J Twomey, Anthony S Wierzbicki
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Clinical Chemistry|March 26, 2003
Accuracy of cardiovascular risk estimationTimothy M Reynolds, Patrick Twomey, Anthony S Wierzbicki
Journal of Cardiovascular Risk|October 24, 2002
Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetesTimothy M Reynolds, Patrick Twomey, Anthony S Wierzbicki
Current Opinion in Cardiology|March 22, 2018
An update on trials of novel lipid-lowering drugsAnthony S Wierzbicki, Timothy M Reynolds, Adie Viljoen
Lancet (London, England)|April 13, 2005
Cardiovascular risk assessmentAnthony S Wierzbicki, Patrick J Twomey, Timothy M Reynolds
Current Medical Research and Opinion|December 23, 2003
Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for haemoglobin A1cPatrick J Twomey, Anthony S Wierzbicki, Timothy M Reynolds
Lancet (London, England)|April 4, 2003
More on PROSPERAnthony S Wierzbicki, Dimitri P Mikhailidis, Timothy M Reynolds
The American Journal of Cardiology|January 17, 2002
Usefulness of Orlistat in the treatment of severe hypertriglyceridemiaAnthony S Wierzbicki, Timothy M Reynolds, Martin A Crook
European Heart Journal|June 3, 2004
Screening for cardiovascular diseaseAnthony S Wierzbicki, Patrick J Twomey, Timothy M Reynolds
JAMA|April 22, 2004
Use of coronary calcification scores to predict coronary heart diseaseAnthony S Wierzbicki, Patrick J Twomey, Timothy M Reynolds
Current Medical Research and Opinion|June 18, 2004
Concordance evaluation of coronary risk scores: implications for cardiovascular risk screeningTimothy M Reynolds, Patrick J Twomey, Anthony S Wierzbicki
Pageof 4